Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.

Idbaih, Ahmed

Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951. [electronic resource] - Journal of neuro-oncology Jun 2011 - 221-30 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1573-7373

10.1007/s11060-010-0380-9 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Biomarkers, Tumor--analysis
Brain Neoplasms--drug therapy
Chromosome Aberrations
Chromosomes, Artificial, Bacterial
Combined Modality Therapy
Comparative Genomic Hybridization
Humans
In Situ Hybridization, Fluorescence
Kaplan-Meier Estimate
Lomustine--administration & dosage
Male
Middle Aged
Multicenter Studies as Topic
Oligodendroglioma--drug therapy
Procarbazine--administration & dosage
Prognosis
Proportional Hazards Models
Radiotherapy
Retrospective Studies
Treatment Outcome
Vincristine--administration & dosage
Young Adult